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Abstract
Background: Intraosseous (IO) access represents a reliable alternative to intravenous vascular access and is
explicitly recommended in the current guidelines of the European Resuscitation Council when intravenous access
is difficult or impossible. We therefore aimed to study the efficacy of the intraosseous needle driver EZ-IO® in the
prehospital setting.
Methods: During a 24-month period, all cases of prehospital IO access using the EZ-IO® needle driver within three
operational areas of emergency medical services were prospectively recorded by a standardized questionnaire that
needed to be filled out by the rescuer immediately after the mission and sent to the primary investigator. We
determined the rate of successful insertion of the IO needle, the time required, immediate procedure-related
complications, the level of previous experience with IO access, and operator’s subjective satisfaction with the
device.
Results: 77 IO needle insertions were performed in 69 adults and five infants and children by emergency
physicians (n = 72 applications) and paramedics (n = 5 applications). Needle placement was successful at the first
attempt in all but 2 adults (one patient with unrecognized total knee arthroplasty, one case of needle obstruction
after placement). The majority of users (92%) were relative novices with less than five previous IO needle
placements. Of 22 responsive patients, 18 reported pain upon fluid administration via the needle. The rescuers’
subjective rating regarding handling of the device and ease of needle insertion, as described by means of an
analogue scale (0 = entirely unsatisfied, 10 = most satisfied), provided a median score of 10 (range 1-10).
Conclusions: The EZ-IO® needle driver was an efficient alternative to establish immediate out-of-hospital vascular
access. However, significant pain upon intramedullary infusion was observed in the majority of responsive patients.
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Background
Establishing immediate vascular access is a crucial step
in the treatment of critically ill patients. Therefore,
patients with difficult venous access remain a challenge
for paramedics and emergency physicians. Using stan-
dard peripheral intravenous (IV) catheters often requires
multiple attempts, is time consuming and may be ulti-
mately unsuccessful. Unfavorable co-factors, such as
hypovolemia, difficult access to the patient or poor
lighting, can further aggravate these difficulties.
Intraosseous (IO) access represents a reliable alterna-
tive and is increasingly being used in the prehospital set-
ting [1-5] and in the emergency department [6,7].
Further, it is an explicitly recommended procedure in
the current guidelines of the European Resuscitation
Council when intravenous access “cannot be established
within the first 2 min of resuscitation” or is otherwise
“difficult or impossible” [8]. Using manual screw nee-
dles, the Bone Injection Gun (BIG) or a semi-automatic
insertion device (EZ-IO®), the procedure has been
demonstrated to be quick, safe and efficient [1-7,9-12].
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However, data regarding out-of-hospital IO access estab-
lished by relative novices is limited.
The aim of the study was to prospectively evaluate the
efficacy of a battery-powered needle driver (EZ-IO®
Intraosseous Infusion System, Vidacare Inc. Shavano
Park, TX, USA) used by novice users - paramedics and
emergency physicians - in patients with difficult vascular
access in the prehospital environment of three emergency
medical services in Germany and Switzerland.
Materials and methods
Study design and setting
All prehospital needle insertions with the EZ-IO® device
performed by paramedics and emergency physicians
within a 24 month-period were recorded by means of a
standardized questionnaire. The investigation was
exempted by the J.W. Goethe University’s ethics commit-
tee from formal review. The emergency medical services
(EMS) that participated in the study consisted of six
mobile intensive care units, each manned with one para-
medic and one board-certified emergency physician that
operated 24/7, and one rescue helicopter (one paramedic,
one emergency physician, operated during daylight hours
only) in the districts of Frankfurt/Main and Bad Kreuz-
nach in Germany, and a paramedic-based ambulance
system (four units manned with two paramedics each,
operated 24/7) in the Swiss canton Appenzell-Innerrho-
den. The universal access numbers in Germany and
Switzerland are 112 and 144, respectively.
IO access was considered at the sole discretion of the
paramedic or emergency physician in charge. In particu-
lar, there was no study protocol directive to first under-
take a certain number of venous access attempts before
choosing the IO route.
Since 2008, all paramedics and emergency physicians
providing services in these areas undergo training in IO
access with the EZ-IO® that consists of a 15 min hands-
on manikin training on a yearly basis.
EZ-IO® Intraosseous Infusion System
The EZ-IO device is a sealed medical drill to establish IO
access. The lithium battery is capable of performing a
minimum of 500 needle insertions. The needles come in
one diameter (15 Gauge), but different lengths of 15 mm
(pediatrics, 3-39 kg), 25 mm (adults, > 40 kg), and 45 mm
(“excessive tissue”). When touching the bone at least 5 mm
of the needle must be visible to ensure that the tip of the
needle sufficiently enters the medullary space. Further
applying gentle, steady downward pressure, a “pop” is felt
upon entry of the needle into the medullary space.
Data collection and processing
Standardized questionnaires were distributed to all EMS
operators that participated in the study and returned by
mail to the principal investigator immediately after the
rescue mission. In case of further inquiries the rescuer
was contacted over the phone. The questionnaires were
anonymized in terms of patient’s personal data, and
location of the mission. Recorded data recorded
included demographics, indication for IO needle use,
access site, number of previously placed IO needles,
pain upon fluid or drug administration via the needle,
and subjective satisfaction regarding handling of the
device and ease of needle placement.
Outcome measures
The primary outcome variables were overall placement
success of the IO needle. Needle placement was consid-
ered successful when passive bone marrow reflux was
observed or bone marrow could be aspirated. Secondary
variables comprised the site of IO access, number of
previous attempts to establish intravenous access if
applicable, immediate procedure-related complications,
the level of previous experience with IO access, and
operator’s subjective satisfaction with the device.
Statistics
After testing for Gaussian distribution, all data are
expressed as median and range, or number and per-
cent as appropriate. All statistical calculations were
performed with IBM-based software packages (Micro-
soft Excel 2007, Microsoft Deutschland GmbH,
Unterschleißheim, Germany, and GraphPad InStat Ver-
sion 3.06; GraphPad Software Inc., San Diego, CA,
USA).
Results
During a 24 month-period, the participating EMS units
responded to 37,231 calls. The EZ-IO® was used for 77
needle insertions (access site proximal tibia: n = 75; distal
tibia: n = 2) in 69 adult patients (median 66 years [range:
27-91 years], median body mass index 27.3 kg/m2 [range:
13.9-46.9 kg/m2]) and 5 infants and children aged 1, 8
and 10 months, 2 years and 13 years, respectively, by
emergency physicians (n = 72 applications) and parame-
dics (n = 5 applications) (Figure 1).
The indications for obtaining vascular access are
shown in Table 1. In all patients, the consequence of
vascular access was the use of either analgetics or narco-
tics, cardiovascular active drugs (e.g., inotropes, beta
blockers, vasoconstrictors, etc.), naloxone, and fluids.
Needle placement was successful at the first in all
except 2 adults. One had undergone total knee arthro-
plasty which the emergency physician in charge was una-
ware of, and multiple attempts to place the intraosseous
needle into the proximal tibia failed. In the second
patient needle insertion was successful per se, but the
needle was obstructed by osseous chippings, and another
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IO needle was placed into the other tibia. No immediate
procedure-related complications were observed.
The EZ-IO® was used as first-line vascular access
device in ten patients (indications: anticipated difficult
venous access due to a history of intravenous drug
abuse, n = 4; vascular collapse due to hypovolemic
shock, n = 3; and cardiac arrest, n = 3). In the remain-
ing 64 patients, a median of three (range 1-12) attempts
of peripheral venous cannulation failed before IO access
was established.
22 patients were conscious and alert during needle
placement. Although the insertion site was not anesthe-
tized and none of the patients described the needle
insertion as painful, 18 of them reported pain upon fluid
administration via the needle, among them one patient
with multiple injuries in whom fluid resuscitation
needed to be stopped because of massive intramedullary
pain, and a central venous catheter was inserted. Lido-
caine 20-40 mg was given to all 4 patients who did not
complain about injection pain, and to eight of 18
patients who complained.
The rescuers’ subjective rating regarding handling of
the device and ease of needle insertion, as described by
an analogue scale (0 = entirely unsatisfied, 10 = most
satisfied), provided a median score of 10 (range 1-10).
The previous personal level of experience with IO nee-
dle placement is shown in Table 2.
Discussion
The EZ-IO® proved as a feasible, effective and readily
available vascular access device in the prehospital setting
and in the hands of novice users, regardless if emergency
physicians or paramedics. IO access was established on
the first attempt in 97% and failed only once in a patient
with total knee arthroplasty, which can be attributed to
the lack of experience with intraosseous needle place-
ment. The emergency physician in charge did not
remember one key message of the theoretical and hands-
on training: choosing a different access site when needle
placement has failed at one site. In another patient the
needle was apparently placed correctly, but got
obstructed by bony debris. Subsequent needle placement
into the other tibia was uneventful.
Our results are in accordance with another recent report
on the EZ-IO® device [3]. We estimate that in half of our
missions vascular access was required, resulting in a rate
of EZ-IO® use of 0.40% (one per 250 patients requiring
vascular access). In a recent study on French mobile inten-
sive care units Gazin et al. reported on 4,666 patients who
required prehospital vascular access, among them 30
patients in whom the EZ-IO® was used (0.64%; one per
156 patients). The success rate was 84% (first attempt) and
97% (maximum of two attempts) [3]. Both investigations
were performed in an emergency physician-dominated
37.231 calls 
Patients requiring vascular access: 
18.615 (estimated 50% of all missions) 
Difficult vascular access: 
74 patients (0.40%) 
Primary use of EZ-IO: 
10 patients (14%) 
EZ-IO used after 
falied venous access: 
64 patients (86%) 





Figure 1 Study flow chart.
Table 1 Indications for EZ-IO® use in 74 patients
Diagnosis n and (%)
Cardiac arrest 41 (56%)
Multiple trauma 15 (20%)
Myocardial ischemia 5 (7%)
Pulmonary edema 4 (5%)
Drug poisoning 4 (5%)
Stroke/Intracerebral hemorrhage 3 (4%)
Gastrointestinal hemorrhage 2 (3%)
Table 2 Previous personal experience with IO needle
placement
Previously placed intraosseous needles (n = 63 EP/PM)*
None 1-5 6-10 > 10
25 (40%) 32 (50%) 3 (5%) 3 (5%)
Data are number and (%)
EM: emergency physician PM: paramedic
* Regardless of device
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rescue system using the same novel device after a brief
training. Because difficult vascular access was a relative
rarity in both studies, the total number of IO needle place-
ments is low compared to the total number of patients
who required vascular access. Performing a single study
that includes a representative number of patients in whom
out-of-hospital IO access was attempted would probably
require hundreds of thousands of patients. Therefore,
pooling data from several smaller studies conducted in
comparable settings seems to be the most practical
approach to reach a sound conclusion regarding safety
and efficacy of a new, but rare procedure.
Several techniques can be used to insert IO needles, the
best established being manual needles and the spring-
loaded driven BIG. The semi-automatic EZ-IO® is another
access device which is becoming increasingly popular. Stu-
dies in animal and human cadavers demonstrated the
superiority of the EZ-IO® over both, the manual needle
and the BIG, regarding successful insertion on the first
attempt (manual needle 79.5% versus EZ-IO® 97.8%; BIG
69.0% versus EZ-IO® 96.6%) [10,11]. When the EZ-IO®
was compared to the BIG in 40 patients requiring in-hos-
pital cardiopulmonary resuscitation, IO access was estab-
lished more often (90% versus 80%) and faster (1.8 ± 0.9
min versus 2.2 ± 1.0 min) with the EZ-IO®, although
these differences did not reach statistical significance [7].
Sunde et al. also found that the EZ-IO® - when used by
emergency physicians - had a higher overall success rate
than both, the BIG and the manual needle, and an even
significantly higher success rate on first attempt [4].
Pain upon infusion and drug administration was observed
in 18 of 22 responsive patients, regardless of the fact that 8
of them received 20-40 mg lidocaine via the needle before
the infusion was started. However, the 4 patients who did
not complain about pain upon injection had all been given
IO lidocaine immediately after needle placement. In a study
by Cooper et al., 32 needles were inserted in combat casua-
lities in Afghanistan, always using the EZ-IO®. Pain was
observed in all responsive patients with the pain of infusion
exceeding that of the underlying injuries in 3 cases [5]. We
also observed one patient with multiple injuries in whom
the infusion needed to be stopped because of unbearable
pain. The manufacturer recommends lidocaine administra-
tion, 20-40 mg in adults and 0.5 mg/kg in children, to pre-
vent such pain [13]. If this is the optimal dose, however,
needs to be further studied. Nevertheless, based on the
experiences made in our study all emergency physicians
and paramedics are now explicitly advised to first adminis-
ter lidocaine in all conscious patients before injecting any
other drug or administer fluids.
There is an ongoing debate if vascular access should
be established at all costs in the prehospital setting.
Multiple attempts to achieve IV access may prolong the
prehospital treatment time, which can be crucial
especially in trauma patients. We therefore recommend
that IO access should be immediately considered when-
ever a.) vascular access has an impact on the prehospital
treatment regimen of the patient and b.) peripheral
venous access requires more than two attemps or takes
longer than 90 seconds in such patients.
Study limitations
The study has several limitations. It is an observational
cohort study, but did not compare different devices for IO
access in randomized fashion. Furthermore, the decision
for IO access was solely made at the discretion of the res-
cuer in charge. No conclusion can therefore be drawn
regarding the efficacy and the potential benefits of a pre-
hospital “difficult vascular access algorithm” consisting of
both, IV access and alternative measures. Finally, we did
not assess the pain scores during intraosseous infusion/
injection in conscious patients. Flow rates of fluids were
also not measured, and no late complications (e.g., osteo-
myelitis, inflammation, etc.) were assessed.
Conclusion
We demonstrated that the EZ-IO® intraosseous needle
driver was an efficient alternative to establish immediate
out-of-hospital vascular access. However, pain upon
intramedullary infusion was observed in the majority of
responsive patients. If lidocaine administration, as sug-
gested by the manufacturer, significantly reduces injec-
tion pain needs to be further studied.
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